Literature DB >> 7185953

Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

P De Wals, L Hertoghe, I Borlée-Grimée, S De Maeyer-Cleempoel, G Reginster-Haneuse, A Dachy, A Bouckaert, M F Lechat.   

Abstract

During a recrudescence of meningococcal disease mainly due to serogroup B, 1913 notified cases were investigated in Belgium from 1971 to 1976. From 1971 to 1973, 76 secondary cases were reported out of a total of 1455 cases (5.2 per cent); and from 1974 to 1976, nine secondary cases were reported of a total of 458 cases (2.0 per cent). Seventy per cent of the secondary cases occurred within seven days after the Index case. The 4.7 per cent fatality rate among secondary cases was lower than the 9.8 per cent fatality rate among primary cases. The estimated secondary attack rate was 685 per 100 000 among household contacts, 404 per 100 000 among day-care nursery contacts and 77 per 100 000 among pre-elementary school contacts. These attack rates were significantly higher (P less than 0.001) than the incidence rates in the corresponding age-groups in the general community, indicating the need for prophylaxis in these contacts.

Entities:  

Mesh:

Year:  1981        PMID: 7185953     DOI: 10.1016/s0163-4453(81)80009-6

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  30 in total

1.  Managing meningococcal disease case clusters: art or science?

Authors:  K Ardern; S Bowler; R M Hussey; C M Regan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

Review 2.  Infections diseases: meningococcal disease.

Authors:  C A Hart
Journal:  West J Med       Date:  2000-08

3.  An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.

Authors:  S Samuelsson; P Ege; L Berthelsen; I Lind
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

4.  Guidelines for controlling meningococcal disease.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

Review 5.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

6.  Combined administration of meningococcal serogroup B outer membrane vesicle vaccine and conjugated serogroup C vaccine indicated for prevention of meningococcal disease is safe and immunogenic.

Authors:  Ingeborg S Aaberge; Philipp Oster; Oddveig S Helland; Anne-Cathrine Kristoffersen; Ellen Ypma; E Arne Høiby; Berit Feiring; Hanne Nøkleby
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

Review 7.  Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.

Authors:  M R Hoek; H Christensen; W Hellenbrand; P Stefanoff; M Howitz; J M Stuart
Journal:  Epidemiol Infect       Date:  2008-06-18       Impact factor: 2.451

8.  Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Authors:  B E Kristiansen; Y Tveten; A Jenkins
Journal:  BMJ       Date:  1998-09-05

Review 9.  Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.

Authors: 
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

10.  Risk and prevention of meningococcal disease among education workers: A review.

Authors:  Philippe De Wals; Pierre Deshaies; Gaston De Serres; Bernard Duval; Lise Goulet; Bernard Pouliot; Sylvie Ricard; Maurice Poulin
Journal:  Can J Infect Dis       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.